Avaxim

Avaxim is a vaccine designed to prevent hepatitis A, a viral liver infection. It contains inactivated hepatitis A virus and is administered via intramuscular or subcutaneous routes.

Avaxim is primarily used for the prevention of hepatitis A, a viral infection that can cause liver inflammation. It is often recommended for individuals traveling to regions where hepatitis A is common or for those at higher risk of exposure. The vaccine works by stimulating the body's immune response to the hepatitis A virus, helping to protect against future infections.

Common effects of Avaxim may include mild soreness, redness, or swelling at the injection site. Some individuals might experience mild fever, headache, or fatigue following vaccination. These effects are generally short-lived and resolve on their own without requiring treatment.

Avaxim should be administered by a healthcare professional. Individuals with a history of severe allergic reactions to any component of the vaccine should avoid it. It is important to inform the healthcare provider about any current medications or health conditions before receiving the vaccine.

Avaxim may interact with certain medications or other vaccines. It is advisable to discuss any current medications with a healthcare provider before receiving the vaccine. Additionally, individuals should avoid alcohol consumption immediately before and after vaccination, as it may affect the immune response.